Patients with RA refractory to anti-TNF-alpha may respond to tocilizumab.
- Published in:
- 2010
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2010 AND VI 45 AND IP 9
Results: 17
1
2
Medication safety and reliability. Some antiretroviral drugs used to treat HIV associated with an elevated risk of myocardial infarction.
- Published in:
- 2010
- Publication type:
- Journal Article
3
Opioid abuse and dependence: treatment review and future options.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
4
Focus on... Dronedarone for atrial fibrillation: an update of clinical evidence.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
5
Late-stage product development. Non-Hodgkin's lymphoma: robust NHL drug pipeline calls for comparative trials.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
6
Drug Watch. Pulmonary disease agents.
- Published in:
- Formulary, 2010, v. 45, n. 9, p. 298
- Publication type:
- Article
7
Policy Watch. Risk management, drug safety raise challenges for sponsors and healthcare providers.
- Published in:
- Formulary, 2010, v. 45, n. 9, p. 294
- By:
- Publication type:
- Article
8
Late-stage Product Development. Robust NHL drug pipeline calls for comparative trials.
- Published in:
- Formulary, 2010, v. 45, n. 9, p. 274
- By:
- Publication type:
- Article
9
Meeting Coverage. CYPlA2-inducing medications improve platelet responsiveness to clopidogrel.
- Published in:
- Formulary, 2010, v. 45, n. 9, p. 293
- Publication type:
- Article
10
Medication Safety and Reliability. Some antiretroviral drugs used to treat HIV associated with an elevated risk of myocardial infarction.
- Published in:
- Formulary, 2010, v. 45, n. 9, p. 292
- Publication type:
- Article
11
Opioid abuse and dependence: Treatment review and future options.
- Published in:
- Formulary, 2010, v. 45, n. 9, p. 284
- By:
- Publication type:
- Article
12
Focus on... Dronedarone for atrial fibrillation: An update of clinical evidence.
- Published in:
- Formulary, 2010, v. 45, n. 9, p. 275
- By:
- Publication type:
- Article
13
Meeting Coverage. Patients with RA refractory to anti-TNF-α may respond to tocilizumab.
- Published in:
- Formulary, 2010, v. 45, n. 9, p. 293
- Publication type:
- Article
14
FDA Drug Approvals. FDA actions in brief.
- Published in:
- Formulary, 2010, v. 45, n. 9, p. 273
- Publication type:
- Article
15
FDA Drug Approvals. New biologic: Glassia.
- Published in:
- Formulary, 2010, v. 45, n. 9, p. 272
- Publication type:
- Article
16
FDA Drug Approvals. New combination: Jalyn.
- Published in:
- Formulary, 2010, v. 45, n. 9, p. 272
- Publication type:
- Article
17
FDA Drug Approvals. Pipeline preview.
- Published in:
- Formulary, 2010, v. 45, n. 9, p. 272
- Publication type:
- Article